What is Aveanna Healthcare Holdings, Inc.'s earnings per share (EPS)?

Aveanna Healthcare Holdings, Inc. (AVAH) reported diluted earnings per share of $1.05 for fiscal year 2026. This represents a 1850.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Aveanna Healthcare Holdings, Inc. Financials

AVAH

Source SEC Filings (10-K/10-Q) Updated Mar 19, 2026 Currency USD FYE March

This page shows Aveanna Healthcare Holdings, Inc. (AVAH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 47/100

Based on FY2026 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Aveanna Healthcare Holdings, Inc. has an operating margin of 10.5%, meaning the company retains $11 of operating profit per $100 of revenue. This results in a moderate score of 46/100, indicating healthy but not exceptional operating efficiency. This is up from 6.9% the prior year.

Growth

Aveanna Healthcare Holdings, Inc.'s revenue surged 20.2% year-over-year to $2.4B, reflecting rapid business expansion. This strong growth earns a score of 67/100.

Leverage

Aveanna Healthcare Holdings, Inc. has elevated debt relative to equity (D/E of 6.62), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity

Aveanna Healthcare Holdings, Inc.'s current ratio of 1.32 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 22/100, which could limit financial flexibility.

Returns

100

Aveanna Healthcare Holdings, Inc. earns a strong 115.7% return on equity (ROE), meaning it generates $116 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 100/100.

Altman Z-Score Distress

1.36

Aveanna Healthcare Holdings, Inc. scores 1.36, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Piotroski F-Score Neutral

5/9

Aveanna Healthcare Holdings, Inc. passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed

0.56x

For every $1 of reported earnings, Aveanna Healthcare Holdings, Inc. generates $0.56 in operating cash flow ($125.9M OCF vs $225.0M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

1.8x

Aveanna Healthcare Holdings, Inc. earns $1.8 in operating income for every $1 of interest expense ($256.5M vs $140.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.4B

YoY+20.2%

5Y CAGR+11.9%

Aveanna Healthcare Holdings, Inc. generated $2.4B in revenue in fiscal year 2026. This represents an increase of 20.2% from the prior year.

EBITDA

$267.0M

YoY+77.3%

5Y CAGR+38.0%

Aveanna Healthcare Holdings, Inc.'s EBITDA was $267.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 77.3% from the prior year.

Net Income

$225.0M

YoY+2159.1%

Aveanna Healthcare Holdings, Inc. reported $225.0M in net income in fiscal year 2026. This represents an increase of 2159.1% from the prior year.

EPS (Diluted)

$1.05

YoY+1850.0%

Aveanna Healthcare Holdings, Inc. earned $1.05 per diluted share (EPS) in fiscal year 2026. This represents an increase of 1850.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$193.3M

YoY+129.3%

Aveanna Healthcare Holdings, Inc. held $193.3M in cash against $1.3B in long-term debt as of fiscal year 2026.

Dividends Per Share

N/A

Shares Outstanding

218M

YoY+12.6%

Aveanna Healthcare Holdings, Inc. had 218M shares outstanding in fiscal year 2026. This represents an increase of 12.6% from the prior year.

Margins & Returns

Gross Margin

24.3%

YoY-7.1pp

5Y CAGR-6.0pp

Aveanna Healthcare Holdings, Inc.'s gross margin was 24.3% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 7.1 percentage points from the prior year.

Operating Margin

10.5%

YoY+3.6pp

5Y CAGR+7.7pp

Aveanna Healthcare Holdings, Inc.'s operating margin was 10.5% in fiscal year 2026, reflecting core business profitability. This is up 3.6 percentage points from the prior year.

Net Margin

9.3%

YoY+9.8pp

5Y CAGR+14.8pp

Aveanna Healthcare Holdings, Inc.'s net profit margin was 9.3% in fiscal year 2026, showing the share of revenue converted to profit. This is up 9.8 percentage points from the prior year.

Return on Equity

115.7%

5Y CAGR+144.0pp

Aveanna Healthcare Holdings, Inc.'s ROE was 115.7% in fiscal year 2026, measuring profit generated per dollar of shareholder equity.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

AVAH Income Statement

Metric	FY26	FY24	FY23	FY22	FY21	FY19
Revenue	$2.4B+20.2%	$2.0B+6.8%	$1.9B+6.0%	$1.8B+19.6%	$1.5B+8.0%	$1.4B
Cost of Revenue	$1.6B+16.8%	$1.4B+6.9%	$1.3B+5.3%	$1.2B+18.6%	$1.0B+7.9%	$964.8M
Gross Profit	$591.8M-6.9%	$635.5M+6.7%	$595.4M+7.6%	$553.2M+21.7%	$454.5M+8.4%	$419.3M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$374.5M+6.1%	$352.8M-2.3%	$361.0M+1.0%	$357.2M+48.3%	$240.9M+5.8%	$227.8M
Operating Income	$256.5M+83.5%	$139.8M+1631.8%	$8.1M+101.3%	-$642.3M-18319.2%	-$3.5M-109.0%	$39.0M
Interest Expense	$140.1M-10.5%	$156.6M+2.2%	$153.2M+42.3%	$107.7M+29.8%	$83.0M-10.1%	$92.3M
Income Tax	-$118.1M-838.0%	$16.0M+457.8%	-$4.5M-151.2%	-$1.8M-133.5%	$5.3M+257.7%	$1.5M
Net Income	$225.0M+2159.1%	-$10.9M+91.9%	-$134.5M+79.7%	-$662.0M-1060.4%	-$57.0M+25.4%	-$76.5M
EPS (Diluted)	$1.05+1850.0%	$-0.06+91.5%	$-0.71+80.1%	$-3.57	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$621.9M+5.5%	$589.6M+5.4%	$559.2M+7.6%	$519.9M+2.1%	$509.0M+0.8%	$505.0M+2.9%	$490.7M+2.5%	$478.8M
Cost of Revenue	$419.1M+10.7%	$378.8M+0.8%	$375.7M+7.9%	$348.1M-0.3%	$349.3M+0.8%	$346.7M+0.5%	$344.8M+4.4%	$330.4M
Gross Profit	$202.8M-3.8%	$210.8M+14.8%	$183.6M+6.9%	$171.7M+7.5%	$159.7M+0.9%	$158.3M+8.5%	$145.9M-1.7%	$148.4M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$95.4M+5.9%	$90.1M-1.4%	$91.4M+3.0%	$88.7M+0.6%	$88.2M+0.2%	$88.0M+0.1%	$87.9M+1.0%	$87.0M
Operating Income	$53.6M-33.0%	$80.0M+54.5%	$51.8M+13.2%	$45.8M+34.5%	$34.0M-8.4%	$37.1M+62.4%	$22.9M-21.9%	$29.3M
Interest Expense	$35.1M-2.4%	$36.0M-0.9%	$36.3M-4.6%	$38.1M-2.9%	$39.2M-0.9%	$39.6M-0.1%	$39.6M-0.1%	$39.7M
Income Tax	-$647K-103.8%	$17.1M+245.4%	$5.0M+320.7%	-$2.2M-114.5%	$15.5M+256.3%	-$9.9M-178.4%	$12.7M+316.1%	-$5.9M
Net Income	$14.1M-48.0%	$27.0M+420.4%	$5.2M-82.2%	$29.2M+168.1%	-$42.8M-408.1%	$13.9M+224.5%	-$11.2M+56.6%	-$25.7M
EPS (Diluted)	$0.06-53.8%	$0.13+333.3%	$0.03	N/A	$-0.22-414.3%	$0.07+216.7%	$-0.06	N/A

AVAH Balance Sheet

Metric	FY26	FY24	FY23	FY22	FY21	FY19
Total Assets	$2.0B+21.0%	$1.7B+3.1%	$1.6B-5.8%	$1.7B-4.8%	$1.8B	N/A
Current Assets	$560.2M+42.7%	$392.7M+24.7%	$314.9M+16.7%	$269.8M-8.0%	$293.2M	N/A
Cash & Equivalents	$193.3M+129.3%	$84.3M+91.8%	$43.9M+128.7%	$19.2M-71.4%	$67.1M	N/A
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$313.4M+18.2%	$265.2M+12.1%	$236.6M+6.9%	$221.2M+13.0%	$195.7M	N/A
Goodwill	$1.1B+6.3%	$1.1B0.0%	$1.1B-9.1%	$1.2B-12.0%	$1.3B+7.4%	$1.2B
Total Liabilities	$1.8B+1.8%	$1.8B+2.6%	$1.7B+1.4%	$1.7B+12.6%	$1.5B	N/A
Current Liabilities	$424.5M+5.5%	$402.2M+13.4%	$354.8M+8.7%	$326.5M+57.4%	$207.5M	N/A
Long-Term Debt	$1.3B+1.2%	$1.3B-0.4%	$1.3B-0.4%	$1.3B+10.1%	$1.2B	N/A
Total Equity	$194.5M+257.4%	-$123.6M+4.6%	-$129.6M-1953.4%	-$6.3M-102.3%	$271.5M+0.5%	$270.2M
Retained Earnings	-$1.2B+16.3%	-$1.4B-0.8%	-$1.4B-10.9%	-$1.2B-173.7%	-$451.8M	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$1.8B+2.2%	$1.8B+6.6%	$1.7B-0.2%	$1.7B+1.2%	$1.6B-1.2%	$1.7B+1.3%	$1.6B+1.9%	$1.6B
Current Assets	$502.6M+11.7%	$449.9M+10.4%	$407.6M+3.8%	$392.7M+3.0%	$381.4M+4.8%	$364.0M+8.3%	$336.0M+6.7%	$314.9M
Cash & Equivalents	$145.9M+44.8%	$100.7M+40.9%	$71.5M-15.2%	$84.3M+7.4%	$78.5M+64.6%	$47.7M+11.9%	$42.6M-3.0%	$43.9M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$312.8M-1.1%	$316.3M+7.3%	$294.8M+11.2%	$265.2M-0.1%	$265.4M-2.8%	$273.0M+6.0%	$257.5M+8.9%	$236.6M
Goodwill	$1.1B-0.2%	$1.1B+6.1%	$1.1B0.0%	$1.1B0.0%	$1.1B0.0%	$1.1B0.0%	$1.1B0.0%	$1.1B
Total Liabilities	$1.8B+1.0%	$1.8B+1.3%	$1.8B-1.5%	$1.8B-0.8%	$1.8B+1.0%	$1.8B+0.3%	$1.8B+2.1%	$1.7B
Current Liabilities	$409.7M-1.1%	$414.2M+6.7%	$388.3M-3.4%	$402.2M-1.0%	$406.0M+4.3%	$389.1M+1.9%	$381.9M+7.7%	$354.8M
Long-Term Debt	$1.3B+1.6%	$1.3B-0.1%	$1.3B-0.1%	$1.3B-0.3%	$1.3B+0.1%	$1.3B-0.1%	$1.3B-0.1%	$1.3B
Total Equity	$9.2M+176.6%	-$12.0M+88.0%	-$100.1M+19.0%	-$123.6M+21.0%	-$156.4M-31.5%	-$119.0M+12.7%	-$136.3M-5.2%	-$129.6M
Retained Earnings	-$1.3B+1.0%	-$1.3B+2.0%	-$1.4B+0.4%	-$1.4B+2.1%	-$1.4B-3.1%	-$1.4B+1.0%	-$1.4B-0.8%	-$1.4B

AVAH Cash Flow Statement

Metric	FY26	FY24	FY23	FY22	FY21	FY19
Operating Cash Flow	$125.9M+285.6%	$32.6M+44.0%	$22.7M+146.8%	-$48.4M-141.5%	$116.6M+1438.3%	-$8.7M
Capital Expenditures	N/A	N/A	N/A	$15.9M+4.7%	$15.2M-8.4%	$16.6M
Free Cash Flow	N/A	N/A	N/A	-$27.3M-126.9%	$101.4M+499.9%	-$25.4M
Investing Cash Flow	-$22.3M-252.9%	-$6.3M+28.1%	-$8.8M+65.2%	-$25.3M+86.9%	-$193.5M-985.9%	-$17.8M
Financing Cash Flow	$5.4M-61.4%	$14.0M+29.3%	$10.8M-82.6%	$62.4M-70.4%	$210.9M+864.8%	$21.9M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$33.2M-35.6%	$51.6M+697.4%	-$8.6M-164.4%	$13.4M-54.4%	$29.4M+1524.9%	$1.8M+115.1%	-$12.0M-298.4%	-$3.0M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$2.0M+87.4%	-$16.0M-580.7%	-$2.3M-53.6%	-$1.5M+30.9%	-$2.2M-74.4%	-$1.3M+3.0%	-$1.3M+16.6%	-$1.6M
Financing Cash Flow	$13.9M+319.9%	-$6.3M-249.7%	-$1.8M+70.0%	-$6.1M-267.2%	$3.6M-19.8%	$4.5M-62.2%	$11.9M+5305.0%	$221K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

AVAH Financial Ratios

Metric	FY26	FY24	FY23	FY22	FY21	FY19
Gross Margin	24.3%-7.1pp	31.4%-0.0pp	31.4%+0.5pp	30.9%+0.6pp	30.4%+0.1pp	30.3%
Operating Margin	10.5%+3.6pp	6.9%+6.5pp	0.4%+36.4pp	-35.9%-35.7pp	-0.2%-3.0pp	2.8%
Net Margin	9.3%+9.8pp	-0.5%+6.6pp	-7.1%+29.9pp	-37.0%-33.2pp	-3.8%+1.7pp	-5.5%
Return on Equity	115.7%	N/A	N/A	-17.6%+3.4pp	-21.0%+7.3pp	-28.3%
Return on Assets	11.2%+11.8pp	-0.7%+7.7pp	-8.3%+30.3pp	-38.7%-35.5pp	-3.2%	N/A
Current Ratio	1.32+0.3	0.98+0.1	0.89+0.1	0.83-0.6	1.41	N/A
Debt-to-Equity	6.62+16.9	-10.29-0.4	-9.85+193.2	-203.02-207.3	4.28	N/A
FCF Margin	N/A	N/A	N/A	-1.6%-8.4pp	6.8%+8.6pp	-1.8%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	32.6%-3.1pp	35.8%+2.9pp	32.8%-0.2pp	33.0%+1.7pp	31.4%+0.0pp	31.3%+1.6pp	29.7%-1.3pp	31.0%
Operating Margin	8.6%-5.0pp	13.6%+4.3pp	9.3%+0.5pp	8.8%+2.1pp	6.7%-0.7pp	7.3%+2.7pp	4.7%-1.5pp	6.1%
Net Margin	2.3%-2.3pp	4.6%+3.7pp	0.9%-4.7pp	5.6%+14.0pp	-8.4%-11.2pp	2.8%+5.0pp	-2.3%+3.1pp	-5.4%
Return on Equity	153.1%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	0.8%-0.8pp	1.5%+1.2pp	0.3%-1.4pp	1.8%+4.4pp	-2.6%-3.5pp	0.8%+1.5pp	-0.7%+0.9pp	-1.6%
Current Ratio	1.23+0.1	1.09+0.0	1.05+0.1	0.98+0.0	0.940.0	0.94+0.1	0.880.0	0.89
Debt-to-Equity	140.39+246.2	-105.86-93.2	-12.69-2.4	-10.29-2.1	-8.15+2.6	-10.71-1.4	-9.36+0.5	-9.85
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

National Health NHC

$2.5B

Ardent Health ARDT

$1.2B

Brookdale Sr Living Inc BKD

$3.3B

P3 HEALTH PARTNERS INC PIII

$9.0M

Select Medical SEM

$2.0B

Frequently Asked Questions

What is Aveanna Healthcare Holdings, Inc.'s annual revenue?

Aveanna Healthcare Holdings, Inc. (AVAH) reported $2.4B in total revenue for fiscal year 2026. This represents a 20.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Aveanna Healthcare Holdings, Inc.'s revenue growing?

Aveanna Healthcare Holdings, Inc. (AVAH) revenue grew by 20.2% year-over-year, from $2.0B to $2.4B in fiscal year 2026.

Is Aveanna Healthcare Holdings, Inc. profitable?

Yes, Aveanna Healthcare Holdings, Inc. (AVAH) reported a net income of $225.0M in fiscal year 2026, with a net profit margin of 9.3%.

What is Aveanna Healthcare Holdings, Inc.'s EBITDA?

Aveanna Healthcare Holdings, Inc. (AVAH) had EBITDA of $267.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Aveanna Healthcare Holdings, Inc. have?

As of fiscal year 2026, Aveanna Healthcare Holdings, Inc. (AVAH) had $193.3M in cash and equivalents against $1.3B in long-term debt.

What is Aveanna Healthcare Holdings, Inc.'s gross margin?

Aveanna Healthcare Holdings, Inc. (AVAH) had a gross margin of 24.3% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Aveanna Healthcare Holdings, Inc.'s operating margin?

Aveanna Healthcare Holdings, Inc. (AVAH) had an operating margin of 10.5% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Aveanna Healthcare Holdings, Inc.'s net profit margin?

Aveanna Healthcare Holdings, Inc. (AVAH) had a net profit margin of 9.3% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

What is Aveanna Healthcare Holdings, Inc.'s return on equity (ROE)?

Aveanna Healthcare Holdings, Inc. (AVAH) has a return on equity of 115.7% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Aveanna Healthcare Holdings, Inc.'s operating cash flow?

Aveanna Healthcare Holdings, Inc. (AVAH) generated $125.9M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Aveanna Healthcare Holdings, Inc.'s total assets?

Aveanna Healthcare Holdings, Inc. (AVAH) had $2.0B in total assets as of fiscal year 2026, including both current and long-term assets.

How many shares does Aveanna Healthcare Holdings, Inc. have outstanding?

Aveanna Healthcare Holdings, Inc. (AVAH) had 218M shares outstanding as of fiscal year 2026.

What is Aveanna Healthcare Holdings, Inc.'s current ratio?

Aveanna Healthcare Holdings, Inc. (AVAH) had a current ratio of 1.32 as of fiscal year 2026, which is considered adequate.

What is Aveanna Healthcare Holdings, Inc.'s debt-to-equity ratio?

Aveanna Healthcare Holdings, Inc. (AVAH) had a debt-to-equity ratio of 6.62 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Aveanna Healthcare Holdings, Inc.'s return on assets (ROA)?

Aveanna Healthcare Holdings, Inc. (AVAH) had a return on assets of 11.2% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Aveanna Healthcare Holdings, Inc.'s Altman Z-Score?

Aveanna Healthcare Holdings, Inc. (AVAH) has an Altman Z-Score of 1.36, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Aveanna Healthcare Holdings, Inc.'s Piotroski F-Score?

Aveanna Healthcare Holdings, Inc. (AVAH) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Aveanna Healthcare Holdings, Inc.'s earnings high quality?

Aveanna Healthcare Holdings, Inc. (AVAH) has an earnings quality ratio of 0.56x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Aveanna Healthcare Holdings, Inc. cover its interest payments?

Aveanna Healthcare Holdings, Inc. (AVAH) has an interest coverage ratio of 1.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Aveanna Healthcare Holdings, Inc.?

Aveanna Healthcare Holdings, Inc. (AVAH) scores 47 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.